Mon, October 2, 2023

Edward White Reiterated (SNDX) at Strong Buy with Increased Target to $42 on, Oct 2nd, 2023

Edward White of HC Wainwright & Co., Reiterated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $38 to $42 on, Oct 2nd, 2023.

Edward has made no other calls on SNDX in the last 4 months.



There are 7 other peers that have a rating on SNDX. Out of the 7 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Edward


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Wednesday, August 16th, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023